EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Exact Sciences CEO Defends Company Against Short-Seller’s Criticism

(Page 2 of 2)

growth has been modest, which suggests that getting clinicians to not only order Cologuard for the first time, but re-order the test for more patients afterward, will likely remain a focus area for Exact.

Single PageCurrently on Page: 1 2 previous page